查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511931

胰島素筆市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區、細分市場預測，2024-2030 年

Insulin Pens Market Size, Share & Trends Analysis Report By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare, Others), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

胰島素筆市場成長與趨勢：

Grand View Research最新報告顯示，預計到2030年，全球胰島素筆市場規模將達到124.1億美元。預計 2024 年至 2030 年期間複合年成長率將達到 8.08%。推動市場成長的主要因素是全球糖尿病盛行率的上升。根據國際糖尿病聯盟的數據，2021 年約有 5.37 億成年人患有糖尿病，預計到 2030 年將增加至 6.43 億人。這一不斷成長的數字極大地刺激了對有效且方便的胰島素輸送方法（例如胰島素筆）的需求。

該國際協議旨在 2025 年遏止糖尿病和肥胖症的上升。目前，全球約 4.22 億糖尿病患者中的大多數居住在低收入國家，其中 2 型糖尿病每年導致 150 萬人死亡。近幾十年來，糖尿病盛行率穩定上升。根據IDF糖尿病圖譜的最新資料，全球糖尿病盛行率為10.5%，其中近44.7%的人未被診斷。根據IDF未來預測，到2045年，成年糖尿病患者人數可能達到7.83億，約佔全球人口的12.5%，成長46%。這一成長趨勢遠超過同期世界人口20%的預期成長率。

胰島素筆技術的進步、老年人口的增加以及各地區醫療基礎設施投資的增加對於市場擴張至關重要。此外，相對於傳統注射器和管瓶，向現代胰島素輸送設備的轉變在市場擴張中發揮關鍵作用。然而，市場面臨挑戰，例如胰島素筆治療的​​高成本以及新興國家有限的報銷政策。儘管存在這些障礙，研究和開發工作仍在進行中，以推出創新且具有成本效益的胰島素筆，並有望克服這些障礙。

胰島素筆全球市場報告亮點

  • 按類型分類，胰島素筆市場分為一次性胰島素筆和可重複使用胰島素筆，其中一次性筆因其方便和衛生的優點而佔據最大的市場佔有率。
  • 依最終用途分類，胰島素筆市場分為醫院和診所、居家照護等。其中，居家照護領域佔最大市場佔有率， 2023年為48.21%。
  • 此外，由於醫療基礎設施完善、糖尿病盛行率高以及市場領導者的強大影響力，北美胰島素筆市場在 2023 年佔據主導地位，收益佔有率最高，達到 40.73%。
  • 受中國和印度等新興經濟體醫療保健支出增加、糖尿病意識提高以及醫療保健設施改善的推動，預計亞太地區在預測期內將實現 8.8% 的最快成長率 (CAGR)。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章胰島素筆市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 胰島素筆市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章胰島素筆市場：類型估計和趨勢分析

  • 細分儀表板
  • 全球胰島素筆市場波動分析
  • 2018-2030年全球胰島素筆市場規模及趨勢分析（按類型）
  • 可重覆使用胰島素筆
  • 拋棄式胰島素筆

第5章胰島素筆市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 全球胰島素筆終端用途市場波動分析
  • 2018-2030 年全球胰島素筆市場規模與趨勢分析（依最終用途）
  • 醫院/診所
  • 居家護理
  • 其他

第6章胰島素筆市場：按產品、應用、模式和最終用途的區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2023年主要企業市場佔有率分析
  • Company Position Analysis
  • 公司分類（新興企業、創新企業、領導者）
  • 公司簡介
    • Medtronic Plc
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly and Company
    • Ypsomed AG
    • Insulet Corporation
    • B. Braun SE
    • Owen Mumford Ltd.
    • Tandem Diabetes Care, Inc.
Product Code: GVR-4-68040-302-6

Insulin Pens Market Growth & Trends:

The global insulin pens market size is anticipated to reach USD 12.41 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.08% during the forecast period, 2024 to 2030. Key drivers propelling market growth include rising prevalence of diabetes worldwide. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number expected to rise to 643 million by 2030. This escalating figure has significantly fueled the demand for effective and convenient insulin delivery methods, such as insulin pens.

The international agreement aims to stop the rise of diabetes and obesity by 2025. Currently, the majority of the global diabetic population of approximately 422 million resides in lower-income countries, contributing to 1.5 million deaths annually due to type 2 diabetes. Over recent decades, there has been a steady increase in diabetes rates. The latest data from the IDF Diabetes Atlas indicates a global diabetes prevalence rate of 10.5%, with nearly 44.7% of cases remaining undiagnosed. Future forecasts from the IDF suggest that by 2045, the number of adults with diabetes could reach 783 million, or roughly 12.5% of the global population, marking a 46% increase. This uptrend significantly outpaces the anticipated global population growth of 20% for the same timeframe.

Advancements in insulin pen technology, the growing geriatric population, and increasing investments in healthcare infrastructure across various regions have been crucial in market expansion. Furthermore, the shift towards modern insulin delivery devices over traditional syringes and vials has played a pivotal role in market expansion. However, the market faces challenges such as high costs associated with insulin pen therapy and limited reimbursement policies in developing countries. Despite these barriers, ongoing research and development efforts to introduce innovative, cost-effective insulin pens are anticipated to overcome these hurdles.

Global Insulin Pens Market Report Highlights:

  • By type, the insulin pens market is categorized into disposable and reusable insulin pens, with disposable pens holding the largest market share due to their convenience and hygiene benefits
  • By end use, the insulin pens market is segmented into hospitals & clinics, homecare, and others. Among these, homecare segment captured the largest market share of 48.21% in 2023
  • Furthermore, North America insulin pens market dominated the market by capturing the highest revenue share of 40.73% in 2023 owing to its well-established healthcare infrastructure, high diabetes prevalence, and strong presence of leading market players
  • The Asia Pacific region is expected to witness the fastest growth rate (CAGR) of 8.8% during the forecast period, driven by increasing healthcare expenditure, rising diabetes awareness, and improving healthcare facilities in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Pens Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in the prevalence of diabetes globally
      • 3.2.1.2. Advancements in technology and development of smart insulin pens
      • 3.2.1.3. Growing awareness and education about diabetes management
      • 3.2.1.4. Increasing government initiatives and support to provide accessible and affordable diabetes treatment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of smart insulin pens
      • 3.2.2.2. Lack of awareness and education about advanced diabetes management tools
      • 3.2.2.3. Stringent regulatory approvals
  • 3.3. Insulin Pens Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Insulin Pens Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Insulin Pens Type Market Movement Analysis
  • 4.3. Global Insulin Pens Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Reusable Insulin Pens
    • 4.4.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Disposable Insulin Pens
    • 4.5.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Insulin Pens Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Insulin Pens End Use Market Movement Analysis
  • 5.3. Global Insulin Pens Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Pens Market: Regional Estimates & Trend Analysis By Product , Application, Modality, End Use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. Medtronic Plc
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Novo Nordisk A/S
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Sanofi
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Eli Lilly and Company
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Ypsomed AG
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Insulet Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. B. Braun SE
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Owen Mumford Ltd.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Tandem Diabetes Care, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 5 North America insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 7 U.S. insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 9 Canada insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 11 Mexico insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 13 Europe insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 14 Europe insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 15 UK insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 16 UK insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 18 Germany insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 19 France insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 20 France insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 22 Italy insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 24 Denmark insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 26 Sweden insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 28 Norway insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Japan insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 33 Japan insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 34 China insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 35 China insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 36 India insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 37 India insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Australia insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 39 Australia insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 41 South Korea insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 43 Thailand insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America insulin pens market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Latin America insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 46 Latin America insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 48 Brazil insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 49 Argentina insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 50 Argentina insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa insulin pens market, By country, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 South Africa insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 55 South Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 58 UAE insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 59 UAE insulin pens market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait insulin pens market, By type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait insulin pens market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Insulin pens market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Insulin pens market driver impact
  • Fig. 19 Insulin pens market restraint impact
  • Fig. 20 Insulin pens market: Type movement analysis
  • Fig. 21 Insulin pens market: Type outlook and key takeaways
  • Fig. 22 Reusable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 23 Disposable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 24 Insulin pens market: End use movement analysis
  • Fig. 25 Insulin pens market: End use outlook and key takeaways
  • Fig. 26 Hospitals and clinics market estimates and forecast, 2018 - 2030
  • Fig. 27 Homecare market estimates and forecast, 2018 - 2030
  • Fig. 28 Others end users market estimates and forecast, 2018 - 2030
  • Fig. 29 Global insulin pens market: Regional movement analysis
  • Fig. 30 Global insulin pens market: Regional outlook and key takeaways
  • Fig. 31 North America
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.S.
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 37 Mexico
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 39 Europe
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 41 UK
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 45 France
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 55 Norway
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 57 Asia Pacific
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 59 China
  • Fig. 60 China market estimates and forecasts, 2018 - 2030
  • Fig. 61 Japan
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 63 India
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Thailand
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Korea
  • Fig. 68 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 69 Australia
  • Fig. 70 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 71 Latin America
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Mexico
  • Fig. 76 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 77 Argentina
  • Fig. 78 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 79 Middle East and Africa
  • Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 81 South Africa
  • Fig. 82 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 83 Saudi Arabia
  • Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 85 UAE
  • Fig. 86 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 87 Kuwait
  • Fig. 88 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 89 Market share of key market players- Insulin pens market